Related Experiment Video
Updated: Jul 11, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
[Persistent central diabetes insipidus in a very low birth weight infant]
Insights
Central diabetes insipidus (DI) is rare in newborns. This case study shows successful treatment of idiopathic DI in a premature infant using oral desmopressin, with low doses maintained after discharge.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
- Rare Diseases
Background:
- Central diabetes insipidus (DI) is uncommon in neonates, often linked to identifiable causes.
- Desmopressin is an effective treatment, but requires individualized dosing via nasal or oral routes.
Observation:
- A case of idiopathic central DI is presented in a very low birth weight infant within the first month of life.
Findings:
- Successful management of neonatal central DI was achieved using oral desmopressin.
- Low-dose oral desmopressin therapy was continued post-discharge, demonstrating sustained efficacy.
Implications:
- This case highlights the feasibility of oral desmopressin for treating neonatal idiopathic central DI.
- Individualized, low-dose desmopressin therapy can be a viable long-term treatment option for affected infants.
Abstract:
Central diabetes insipidus (DI) is extremely rare during the neonatal period. Most cases of central DI are secondary to a known aetiology. Substitutive treatment with desmopressin is effective with nasal or oral preparation, but doses are variable and must be tailored individually. We report on a case in a very low birth weight infant with an idiopathic central DI during the first month of life. He was successfully treated with oral desmopressin. The treatment was maintained after discharge with low doses desmospressin.
Related Concept Videos
Diabetes Insipidus I: Introduction
Diabetes Insipidus II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes III: Clinical Manifestations
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
